Stem Cell Transplants
"CD34+CD33- Cells Influence Days to Engraftment and Transfusion Requirements in Autologous Blood Stem-Cell Recipients."
Published in Blood Weekly, August 10th, 1998
According to the authors' abstract of an article published in Journal of Clinical Oncology, "Purpose: To evaluate the reliability of CD34/CD33 subset enumeration as a predictor of hematopoietic repopulating potential in autologous blood stem-cell transplantation and to determine which patient and treatment-related factors affect the timing, quantity, and type of blood stem cells mobilized. Patients and Methods: We analyzed blood stem-cell collections from 410 consecutive cancer patients who received mobilization therapy and evaluated factors, including CD34+ subset quantities, that might influence engraftment kinetics and transfusion requirements in autologous...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (1998-08-10)
More Articles from Blood Weekly
- Hemophilia C
Factor XI Inhibition May Modulate Thrombin Generation - Bone Marrow Transplantation
Clonal Hematopoiesis Predicts Transplant-Linked Leukemia - Gene Transfer (Hematopoietic Cells)
Retroviral Transduction Sustains Gene Expression In Progeny Cells - HIV Gene Therapy
Results of a Phase I Gene Therapy Trial Presented at Conference - Hematopoiesis
Delayed Targeting of Nonresponsive CD Cells Enhances Transduced Gene Expression - Hematopoiesis
Possible Cross Talk between Retinoic Acid Receptors and Oncoprotein - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
